Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  ductal breast carcinoma
Stage/Subtype:  ductal breast carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 25 for your search:
Start Over
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Status: Active
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
Proton Beam Radiation Therapy or Photon Beam Radiation Therapy in Treating Patients with Non-Metastatic Breast Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 21 and over
Trial IDs: UPCC 19115, NCI-2015-01950, 823440, RTOG 3509, RTOG 3510, UPC 19115, NCT02603341
Accelerated Partial Breast Irradiation in Treating Patients with Low-Risk Stage 0-I Breast Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 50 and over
Trial IDs: 201401160, NCI-2014-00269, NCT02076074
Accelerated Whole Breast Radiotherapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 040807, NCI-2012-00535, CDR0000643276, CINJ-040807, NCT00909909
Radiation Therapy in Treating Patients With Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0818, NCI-2011-01102, NCT01245712
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201301106, NCI-2012-02202, NCT01723774
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients with ERBB2 Expressing Disseminated Tumor Cells
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201309084, NCI-2012-03110, 12-X356, NCT01779050
Accelerated Partial Breast Proton Radiation Therapy in Treating Patients with Stage IA-IIA Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 50 and over
Trial IDs: UPCC 04113, NCI-2013-00861, 817359, NCT01839838
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Boost Radiation Therapy before Surgery in Treating Patients with Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: Pro00063936, NCI-2015-01625, NCT02482389
Single-Fraction Partial Breast Radiation Therapy before Surgery in Treating Patients with Early Stage Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Pro00063848, NCI-2015-01856, NCT02482376
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ATOS-2015-007, NCI-2016-00299, NCT02540330
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients with Early Stage Breast Cancer after Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 45 and over
Trial IDs: 041404, NCI-2015-01156, Pro20150001297, NCT02526498
Letrozole with or without Ribociclib before Surgery in Treating Women with Stage II-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CLEE011XUS10T, NCI-2016-00423, STUDY00002972, NCT02712723
Fulvestrant with or without Ribociclib in Patients with Recurrent, Unresectable, or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AAAP9506, NCI-2016-01092, NCT02632045
Alpelisib and Letrozole with or without Trastuzumab in Post-menopausal Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC BRE 12101, NCI-2013-00102, CBYL719XUS03T, SU2C B07, NCT01791478
Vaccine Therapy with or without Durvalumab in Treating Patients with Stage II-III Triple Negative Breast Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-132, NCI-2016-01368, NCT02826434
Single Fraction Adjuvant SB-PBI in Treating Patients with Stage I-II Breast Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: STU 062015-085, NCI-2016-00084, NCT02685332
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, 302844, P08407, NCT00924027
Broccoli Sprout Extract in Treating Patients with Breast Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: I 211911, NCI-2012-01770, NCT01753908
Caloric Restriction in Treating Patients with Early Stage Breast Cancer Undergoing Surgery and Radiation Therapy
Status: Temporarily closed
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12G.616, NCI-2013-00611, 2012-94, NCT01819233
Metformin Hydrochloride and Atorvastatin Calcium in Treating Patients with Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: IRB-AAAM2306, NCI-2014-01506, AAAM2306, Y1M00, NCT01980823
Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial
Status: Active
Phase: No phase specified
Type: Treatment
Age: 65 and over
Trial IDs: ICMBC-02, NCI-2015-00716, NCT02200705
Prone Breath Hold Technique in Decreasing Heart and Lung Radiation Doses in Patients with Breast Cancer Receiving Left Breast Radiation Therapy
Status: Active
Phase: No phase specified
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: 1409500149, NCI-2015-01120, 1409500149A001, NCT02379988
Ipilimumab, Nivolumab, and Cryosurgery in Treating Patients with Early Stage Breast Cancer Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-495, NCI-2016-01348, NCT02833233
Start Over